Table 3.
Return on investment of preventively vaccinating healthcare workers against pertussis
| Costs in Euros | % | |
|---|---|---|
| Direct control costs | ||
| Antibiotic therapy (a) | €785 | 2% |
| Laboratory investigations (b) | €6,982 | 14% |
| Outbreak control management (c) | €3,697 | 8% |
| Total (a,b,c) | €11,464 | 24% |
| Other outbreak related costs | ||
| Absenteeism costs (d) | €21,008 | 43% |
| Restrictions on patient uptake on the ward (e) | €47,036 | 33% 2 |
| Savings due to reduced staff costs (f) 1 | −/− €30,826 | |
| Total (d,e,f) | €37,218 | 76% |
| Total nosocomial pertussis outbreak costs (g) | €48,682 | 100% |
| Vaccination costs (h) | €12,208 | |
| Ratio | ||
| Return on investment ((g-h)/h) | 1:4 |
1 Reduced work force was required due to ward closure, which led to savings in personnel costs.
2 (€47,036 + €-30,826)/€48,682 = 33%.